Home
Longevity
Diseases of Aging
Status Quo
Stem Cells Solutions
Technologies (ASC, PRC, PPC, pMSC)
Therapeutic focus
Liver
Heart
Arteries
About
Our Mission
Team Management
Patents
Careers
News
Industry News
Bio News Letter
News
Hot Science
Contact
Technologies
Overview
Platforms
STEM CELL REVIVIFY™
Pipeline
About Us
Our Mission
Management Team
Patents
Collaboration Opportunities
Careers
Contact Us
News and Resources
Industry News
Bio News Letter
News and Resources
Science
Contact Us
News and Resources
December 18, 2024
Immorta Bio Advances Lung Cancer Immunotherapy with Peer-Reviewed Animal Data on Senolytic Vaccine
Read more
November 20, 2024
Nature Publication Supports Senolytic Approach for Cancer Treatment
Read more
November 3, 2024
Immorta CSO Featured in BioFuture 2024 Longevity Panel
Read more
October 29, 2024
Immorta Bio's SenoVax™ Reduces Growth and Stops Metastasis of Aggressive Breast Cancer Using its First-In-Class Immune Stimulatory Therapy
Read more
October 21, 2024
Featured on The Bio Report Podcast - Targeting Senescent Cells
Read more
October 17, 2024
Immorta Bio CEO Featured in Empowered Patient Podcast
Read more
October 16, 2024
Immorta Bio - Featured on Pharmaceutical Executive
Read more
October 2, 2024
Diseases of Aging: Q&A with Dr. Thomas Ichim
Read more
September 5, 2024
SenoVax™ Breakthrough: Cancer Immunotherapy Preserves Immune Function Post-Chemotherapy in Animal Models
Read more
August 13, 2024
Immunotherapy Success Reinforces Immorta's Innovative Cancer Treatment Strategy
Read more
July 30, 2024
Dr. Russel Kaufman, Renowned Medical Innovator and Business Leader, Joins Immorta Bio's Board of Directors
Read more
July 26, 2024
Immorta Bio Files Investigational New Drug Application for First in Class Senolytic Immunotherapy SenoVax™ for Treatment of Advanced Lung Cancer
Read more
June 12, 2024
Senovax™: cutting-edge immunotherapy for lung cancer
Read more
June 12, 2024
Immorta Bio Reports Successful Inhibition of Lung Cancer Growth by Senolytic Immunotherapy Product SenoVax™
Read more
May 24, 2024
Pmsc-11: pioneering liver failure treatment with stem cells
Read more
May 23, 2024
Immorta Bio Inc, a Longevity Company, Announces a Significant Breakthrough in Treatment of Liver Failure
Read more
May 7, 2024
Muscle revival: mitochondrial transplants for aging
Read more
April 23, 2024
Young mice plasma sevs: unlocking the secret to longevity
Read more
April 9, 2024
Telomir-1: the next breakthrough in anti-aging therapy
Read more
March 26, 2024
Surprising longevity boosters: top medications revealed
Read more
Next
Subscribe to Immorta Bio Newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Join our newsletter to stay up to date on features and releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By subscribing, you are acknowledging your consent to receive Immorta Bio newsletters
19505 Biscayne Blvd, Ste 2350 Aventura, Florida 33180
305 632-2939
info@immortabio.com
Technologies
Social Media
Pipeline
About Us
News
Investors
Copyright © Immorta Bio, Inc | All Rights Reserved
Privacy Policy
